Vaccinium macrocarpon/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Vaccinium macrocarpon — decreases HOMA-IR
Evidence strength: moderate.Finding“At the end of the study, the mean insulin and HOMA-IR levels were significantly lower in the cranberry group compared with the placebo group.”
Quoted verbatim from Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial.. - Study
- RCT
- Dose
- 144 mg cranberry capsule for 6 months
- Population
- Patients with non-alcoholic fatty liver disease, parallel-group randomized placebo-controlled trial, end of 6-month intervention
Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial.2021PMID:3479889210.1186/s12906-021-03436-6Permalink
To cite this finding: https://catalystproject.ai/e/01M5SSM523WYRN174H2F766V8D